ACTIVE SUBSTANCE / INN

PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Brand name(s): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals), Pumarix
EMA LISTED
WITHDRAWN
AUTHORISED
Influenza, Human;Immunization;Disease Outbreaks
ACTIVE SUBSTANCE
Pandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)GlaxoSmithKline Biologicals S.A.Authorised10/10/2009Influenza, Human;Immunization;Disease Outbreaks
PumarixGlaxoSmithKline Biologicals S.A.Withdrawn04/03/2011Influenza, Human;Immunization;Disease Outbreaks

FULL INTELLIGENCE ON PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →